Picture of Caplin Point Laboratories logo

CAPLIPOINT Caplin Point Laboratories Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Caplin Point Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2,2692,6953,1363,8584,514
Depreciation
Non-Cash Items-43-245-139-165-332
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,626-2,319-709-795-1,918
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities8344472,6583,3682,714
Capital Expenditures-652-767-705-912-1,935
Purchase of Fixed Assets
Other Investing Cash Flow Items-353222651-1,798-241
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,005-545-53.6-2,709-2,176
Financing Cash Flow Items-0.6-4.95-15.4-14.6-7.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities898798-240-407-282
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7357012,362250268